Phathom Pharmaceuticals, Inc.PHATNASDAQ
Loading
Gross Profit Growth Under PressureDecelerating
Percentile Rank74
3Y CAGR+56.4%
Year-over-Year Change
Year-over-year gross profit growth rate
3Y CAGR
+56.4%/yr
Quarterly compound
Percentile
P74
Within normal range
vs 3Y Ago
3.8x
Strong expansion
Streak
2 qtr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| Q4 2025 | 15.29% |
| Q3 2025 | 25.68% |
| Q2 2025 | 39.00% |
| Q1 2025 | -4.08% |
| Q4 2024 | 84.69% |
| Q3 2024 | 135.31% |
| Q2 2024 | 300.27% |
| Q1 2024 | 350.30% |
| Q4 2023 | 372.73% |
| Q3 2023 | 1.63% |
| Q2 2023 | 0.00% |
| Q1 2023 | 100.00% |
| Q4 2022 | 4.00% |
| Q3 2022 | -17.45% |
| Q2 2022 | -16.41% |
| Q1 2022 | 5.19% |
| Q4 2021 | -3.85% |
| Q3 2021 | 0.76% |
| Q2 2021 | -4.80% |
| Q1 2021 | 0.00% |
| Q4 2020 | 0.00% |
| Q3 2020 | 0.00% |
| Q2 2020 | 0.00% |
| Q1 2020 | 0.00% |
| Q4 2019 | 0.00% |
| Q3 2019 | 0.00% |
| Q2 2019 | 0.00% |
| Q1 2019 | 0.00% |
| Q4 2018 | 0.00% |
| Q3 2018 | 0.00% |
| Q2 2018 | 0.00% |
| Q1 2018 | 0.00% |